9.44
-0.13 (-1.36%)
| Previous Close | 9.57 |
| Open | 9.54 |
| Volume | 25,125 |
| Avg. Volume (3M) | 54,506 |
| Market Cap | 144,618,912 |
| Price / Sales | 0.420 |
| Price / Book | 0.330 |
| 52 Weeks Range | |
| Earnings Date | 12 Feb 2025 - 17 Feb 2025 |
| Profit Margin | -84.27% |
| Operating Margin (TTM) | -77.60% |
| Diluted EPS (TTM) | -14.45 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 2.60% |
| Current Ratio (MRQ) | 2.92 |
| Operating Cash Flow (TTM) | -155.48 M |
| Levered Free Cash Flow (TTM) | -89.18 M |
| Return on Assets (TTM) | -25.42% |
| Return on Equity (TTM) | -50.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | American Well Corporation | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | -3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -2.5 |
| Average | -0.90 |
|
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 6.22% |
| % Held by Institutions | 49.23% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Alerce Investment Management, L.P. | 30 Sep 2024 | 523,785 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 15.00 (Wells Fargo, 58.90%) | Buy |
| Median | 12.75 (35.06%) | |
| Low | 10.50 (Morgan Stanley, 11.23%) | Hold |
| Average | 12.75 (35.06%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 7.84 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 13 Jan 2025 | 15.00 (58.90%) | Buy | 7.22 |
| Morgan Stanley | 17 Dec 2024 | 10.50 (11.23%) | Hold | 8.45 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GOTLIB PHYLLIS | - | 7.04 | -1,068 | -7,519 |
| MCNEICE PAUL FRANCIS | - | 7.04 | -98 | -690 |
| PAUNOVICH VUKASIN | - | 7.04 | -444 | -3,126 |
| Aggregate Net Quantity | -1,610 | |||
| Aggregate Net Value ($) | -11,334 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 7.04 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PAUNOVICH VUKASIN | Officer | 02 Jan 2025 | Sell (-) | 444 | 7.04 | 3,126 |
| GOTLIB PHYLLIS | Officer | 02 Jan 2025 | Sell (-) | 1,068 | 7.04 | 7,519 |
| MCNEICE PAUL FRANCIS | Officer | 02 Jan 2025 | Sell (-) | 98 | 7.04 | 690 |
| Date | Type | Details |
|---|---|---|
| 09 Jan 2025 | Announcement | Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services |
| 09 Jan 2025 | Announcement | Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction |
| 18 Dec 2024 | Announcement | Amwell CFO Mark Hirschhorn Expands Leadership Role |
| 04 Nov 2024 | Announcement | Amwell Makes Grants to New Employees Under Inducement Plan |
| 30 Oct 2024 | Announcement | Amwell Announces Results for Third Quarter 2024 |
| 28 Oct 2024 | Announcement | Amwell to participate in upcoming investor conferences |
| 15 Oct 2024 | Announcement | Amwell to report third quarter 2024 operating results |
| 15 Oct 2024 | Announcement | Amwell announces new chief financial officer |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |